These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15075501)

  • 21. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients.
    McCutchan JA; Wu JW; Robertson K; Koletar SL; Ellis RJ; Cohn S; Taylor M; Woods S; Heaton R; Currier J; Williams PL
    AIDS; 2007 May; 21(9):1109-17. PubMed ID: 17502721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy.
    d'Arminio Monforte A; Sabin CA; Phillips A; Sterne J; May M; Justice A; Dabis F; Grabar S; Ledergerber B; Gill J; Reiss P; Egger M;
    Arch Intern Med; 2005 Feb; 165(4):416-23. PubMed ID: 15738371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature.
    Baeuerle M; Schmitt-Haendle M; Taubald A; Mueller S; Walter H; Pfeiffer C; Manger B; Harrer T
    Eur J Med Res; 2005 Jul; 10(7):309-16. PubMed ID: 16055403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and direct damage of organs: disease spectrum before and during the highly active antiretroviral therapy era.
    Moroni M; Antinori S
    AIDS; 2003 Apr; 17 Suppl 1():S51-64. PubMed ID: 12870531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R; Pogány K; Fernandez Garcia E; Jurriaans S; Brinkman K; Schuitemaker H; Miedema F; Lange JM; Prins JM
    AIDS; 2008 Aug; 22(13):1583-8. PubMed ID: 18670217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dementia with features of Alzheimer's disease and HIV-associated dementia in an elderly man with AIDS.
    Brousseau KM; Filley CM; Kaye K; Kiser JJ; Adler LE; Connick E
    AIDS; 2009 May; 23(8):1029-31. PubMed ID: 19414994
    [No Abstract]   [Full Text] [Related]  

  • 30. The neuropsychological profile of symptomatic AIDS and ADC patients in the pre-HAART era: a meta-analysis.
    Cysique LA; Maruff P; Brew BJ
    J Int Neuropsychol Soc; 2006 May; 12(3):368-82. PubMed ID: 16903129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AIDS dementia: 1592 now more available.
    AIDS Treat News; 1997 Nov; (No 282):7. PubMed ID: 11364905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of HIV and aging on neuropsychological function.
    Wendelken LA; Valcour V
    J Neurovirol; 2012 Aug; 18(4):256-63. PubMed ID: 22528478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Highly active antiretroviral therapy of neuro-AIDS. Side effects on the nervous system and interactions].
    Husstedt IW; Reichelt D; Neuen-Jakob E; Hahn K; Kästner F; von Einsiedel R; Vielhaber B; Arendt G; Evers S
    Nervenarzt; 2009 Oct; 80(10):1133-4, 1136-8, 1140-2. PubMed ID: 19322555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurodegeneration and ageing in the HAART era.
    Brew BJ; Crowe SM; Landay A; Cysique LA; Guillemin G
    J Neuroimmune Pharmacol; 2009 Jun; 4(2):163-74. PubMed ID: 19067177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches.
    Kaul M
    Curr Opin Neurol; 2009 Jun; 22(3):315-20. PubMed ID: 19300249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS dementia complex.
    Brew BJ
    Neurol Clin; 1999 Nov; 17(4):861-81. PubMed ID: 10517932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues.
    von Giesen HJ; Arendt G; Berger JR; Levy R
    J Neurovirol; 2002 Dec; 8 Suppl 2():3-7. PubMed ID: 12491145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evolution of neuro-AIDS during the HAART era.
    Goodkin K
    J NeuroAIDS; 2002; 2(3):1-17. PubMed ID: 16873196
    [No Abstract]   [Full Text] [Related]  

  • 39. Rapidly progressive cerebrovascular stenosis and recurrent strokes followed by improvement in HIV vasculopathy.
    Bhagavati S; Choi J
    Cerebrovasc Dis; 2008; 26(4):449-52. PubMed ID: 18818493
    [No Abstract]   [Full Text] [Related]  

  • 40. [HIV- DEMENTIA. A REVIEW THIRTY FIVE YEARS AFTER (1981-2015)].
    Corti M
    Vertex; 2015; 26(121):195-201. PubMed ID: 26650556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.